微生物性蛋白酶的进步:通过基因和酶工程解决工业瓶问题
Nitin Srivastava1, Sunil Kumar Khare2,3
1Enzyme and Microbial Biochemistry Laboratory, Department of Chemistry, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India.
Applied biochemistry and biotechnology
|May 15, 2025
概括
微生物性蛋白酶提供工业效益,但面临着低产量和稳定性等挑战. 先进的基因组和酶工程,包括AI-ML,是克服这些局限性以实现更广泛的商业用途的关键.
科学领域:
- 生物技术是生物技术.
- 酶学 是一种酶学.
- 工业微生物学 工业微生物学
背景情况:
- 微生物性蛋白酶是重要的工业酶,在食品,洗剂,皮革,织品和制药中具有应用.
- 目前的局限性包括低酶产量,稳定性差,净化困难和低于最佳的催化速率,阻碍了工业采用.
- 坚固的微生物是稳定的酶的来源,但产量和净化方面的挑战仍然存在.
研究的目的:
- 审查微生物性蛋白酶,它们的工业应用,以及现有的商业化挑战.
- 探索包括基因和酶工程在内的先进解决方案,以克服这些瓶.
- 突出人工智能-机器学习 (AI-ML) 和 de novo工程在优化酶性能方面的作用.
主要方法:
- 基因组分析以确定新的稳定酶序列.
- 异质生产以提高产量和简化净化.
- 酶工程技术,如定向进化和理性设计.
- 应用AI-ML和计算工具来定制酶.
主要成果:
- 基因组存储库提供了对稳定的酶序列的访问,以改善生产.
- 酶工程策略显著提高了稳定性和催化效率.
- 人工智能-ML和计算方法为工业酶开发提供了精确的数据.
结论:
- 先进的基因组和酶工程方法可以克服微生物性蛋白酶的局限性.
- 人工智能-ML和de novo工程代表了工业酶开发的未来,使定制解决方案成为可能.
- 优化的微生物性蛋白酶对各种工业应用具有重大潜力.
相关概念视频
Bioreactor Controls-III
55
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
55
Scale-Up Processes
89
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
89
Production of Organic Acids
82
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
82
Production of Antibiotics
149
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
149
Production of Pharmaceuticals
68
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
68
Microbial Bioremediation of Plastics
93
Polyethylene terephthalate (PET) is a synthetic polymer widely utilized in the packaging industry, particularly for bottles and containers. Due to its chemical stability and durability, PET accumulates in the environment, contributing significantly to plastic pollution. It comprises repeating units of terephthalic acid and ethylene glycol, resulting in a semi-crystalline structure that is resistant to natural degradation processes.A notable breakthrough in plastic biodegradation came with the...
93


